Skip to main content

Oral evidence transcripts

Science, Innovation and Technology Committee

Committee documents that were published online before May 2010 are available by session on the Pre-2010 Publications page.

Total results 345 (page 4 of 18)
2 March 2022
Inquiry UK Science, Research and Technology Capability and Influence in Global Disease Outbreaks
Witnesses Dr Sarah Scobie (Deputy Director of Research at Nuffield Trust), Ed Humpherson (Director General for Regulation and Head at Office for Statistics Regulation), Professor Graham Medley (Chair at Scientific Pandemic Influenza Group on Modelling (SPI-M).), Dr Raghib Ali (Senior Clinical Research Associate at MRC Epidemiology Unit, University of Cambridge), and Dr Camilla Holten-Møller (Chair, the Expert Group for Mathematical Modelling at Statens Serum Institut, Denmark)
Oral Evidence
23 February 2022
Inquiry Diversity and inclusion in STEM
Witnesses Professor Jeremy Sanders CBE FRS (Chair, Diversity Committee at Royal Society), Clare Viney (CEO at Careers Research Advisory Centre-Vitae), Katherine Mathieson (Chief Executive at British Science Association), Dr Anna Zecharia (Development Board Member at Equality, Diversity and Inclusion in Science and Health (EDIS)), Dr Jake Anders (Deputy Director at UCL Centre for Education Policy and Equalising Opportunities), and Dr Rebecca Montacute (Senior Research and Policy Manager at Sutton Trust)
Oral Evidence
10 February 2022
Inquiry The role of technology, research and innovation in the COVID-19 recovery
Witnesses Professor Frank Coton (Senior Vice Principal and Deputy Vice Chancellor (Academic) at University of Glasgow), Karen Watt (Chief Executive at Scottish Funding Council), Dr Gillian Lang (Deputy Director of Science at Glasgow Science Centre), Dr Lynne O'Hare (Chief Commercial Officer at National Manufacturing Institute Scotland), Elaine Gemmell (Head of Regulatory Affairs at Scottish Health Innovations Ltd), Simon Andrews (Executive Director at Fraunhofer UK), and Dr Stuart Hannah (Founder at MicroPlate Dx)
Oral Evidence
10 February 2022
Inquiry UK space strategy and UK satellite infrastructure
Witnesses Professor Malcolm Macdonald (Chair of Applied Space Technology at University of Strathclyde), and Professor Iain Woodhouse (Professor of Applied Earth Observation at University of Edinburgh)
Oral Evidence
9 February 2022
Inquiry UK space strategy and UK satellite infrastructure
Witnesses Paul Bate (CEO at UK Space Agency), Mark Thomson (Executive Chair at Science and Technology Facilities Council), Hugo Robson (Chief Negotiator at Department for Business, Energy and Industrial Strategy), Kwasi Kwarteng (Secretary of State at Department for Business, Energy and Industrial Strategy), and Rebecca Evernden (Director for Space at Department for Business, Energy and Industrial Strategy)
Oral Evidence
2 February 2022
Inquiry Reproducibility and research integrity
Witnesses Professor Dame Ottoline Leyser (Chief Executive at UK Research and Innovation (UKRI)), James Parry (Chief Executive at UK Research Integrity Office), and George Freeman (Minister for Science, Research and Innovation at Department for Business, Energy and Industrial Strategy)
Oral Evidence
19 January 2022
Inquiry Reproducibility and research integrity
Witnesses Professor Sebastian Vollmer (Professor for Application of Machine Learning at TU Kaiserslautern)
Oral Evidence
12 January 2022
Inquiry UK space strategy and UK satellite infrastructure
Witnesses Josef Aschbacher (Director General at European Space Agency), Dr Hiroshi Yamakawa (President at Japan Aerospace Exploration Agency), Dr Philippe Baptiste (President at Centre national d'études spatiales—French National Space and Research Centre), Tim Johnson (Director of Strategy & Policy at Civil Aviation Authority), and Colin Macleod (Head of UK Space Regulation at Civil Aviation Authority)
Oral Evidence
15 December 2021
Inquiry Reproducibility and research integrity
Witnesses Dr Ben Goldacre (Director at Nuffield Department of Primary Care Health Sciences, University of Oxford), Dr Jessica Butler (Analytical Lead and Research Fellow at University of Aberdeen), Springer Nature, Dr Elizabeth Moylan (Publisher, Research Integrity and Publishing Ethics at Wiley), The Lancet, Viscount Ridley (Co-author at Viral: The Search for the Origin of Covid-19), and Dr Alina Chan (Co-author at Viral: The Search for the Origin of Covid-19)
Oral Evidence
14 December 2021
Inquiry UK Science, Research and Technology Capability and Influence in Global Disease Outbreaks
Witnesses Dame Kate Bingham (Former Chair at UK Vaccine Taskforce), Dr Angelique Coetzee (Chair at South African Medical Association), Joint Committee on Vaccination and Immunisation, Moderna, UK Health Security Agency, and UK Health Security Agency
Oral Evidence
8 December 2021
Inquiry UK space strategy and UK satellite infrastructure
Witnesses Yasrine Ibnyahya (Director of Advanced Concepts at Inmarsat), Professor Sir Martin Sweeting (Founder and Executive Chairman at Surrey Satellite Technologies Ltd), Dr Hina Khan (Senior Project Manager and UK Stakeholder Engagement at Spire Global Limited), Jon Styles (Director at Assimila), and Chris McLaughlin (Chief of Government, Regulatory Affairs, and Engagement at OneWeb)
Oral Evidence
1 December 2021
Inquiry Reproducibility and research integrity
Witnesses Professor Neil Ferguson OBE (Professor of Mathematical Biology at Imperial College London), Professor Dorothy Bishop (Professor of Developmental Neuropsychology at University of Oxford), Professor Marcus Munafò (Chair at UK Reproducibility Network Steering Group), Dr Ivan Oransky (Co-Founder at Retraction Watch, Editor at Spectrum, and Distinguished Writer in Residence at New York University's Arthur Carter Journalism Institute), and Dr Janine Austin Clayton (Associate Director for Research on Women’s Health and Director at Office of Research on Women’s Health at the United States National Institute for Health)
Oral Evidence
25 November 2021
Inquiry The role of technology, research and innovation in the COVID-19 recovery
Witnesses Andy Street CBE (Mayor at West Midlands Combined Authority), Dr Clive Hickman (Chief Executive at The Manufacturing Technology Centre), Professor Simon Collinson (Director at City-REDI, University of Birmingham), Tony Kinsella (Chief Executive at Lucideon), Stephen Malone (Group CEO at Malone Group), Professor Martin Freer (Director at Energy Research Accelerator (ERA)), and Professor Daniel Smith (Executive Director, Global Cell and Gene Therapy Portfolio at Cobra Biologics)
Oral Evidence
17 November 2021
Inquiry UK space strategy and UK satellite infrastructure
Witnesses Dan Hart (CEO at Virgin Orbit), Nicholas Smith (Regional Director for UK and Europe at Lockheed Martin Space), Alan Thompson (Head of Government Affairs at Skyrora Limited), Melissa Thorpe (Head at Spaceport Cornwall), Scott Hammond (Deputy Chief Executive Officer at SaxaVord Spaceport), and Pete Guthrie (Senior Programme Manager at Space Hub Sutherland)
Oral Evidence
3 November 2021
Inquiry UK space strategy and UK satellite infrastructure
Witnesses Professor Washington Yotto Ochieng (Chair in Positioning and Navigation Systems at Imperial College London), Lucy Edge (Chief Operating Officer at Satellite Applications Catapult), Professor Anu Ojha (Director at National Space Academy), and Professor David Southwood (Senior Research Investigator at Imperial College London)
Oral Evidence
26 October 2021
Inquiry UK Science, Research and Technology Capability and Influence in Global Disease Outbreaks
Witnesses Professor Andrew Curran (Chief Scientific Adviser and Director of Research at Health and Safety Executive), Professor Mario Mondelli (Professor and Director of Infectious Diseases at University of Pavia), Professor Sir Andrew Pollard (Professor of Paediatric Infection and Immunity at University of Oxford, and Director at Oxford Vaccine Group), Dr Sharon Alroy-Preis (Director at Public Health Services, Israel), Professor Sir Stephen Holgate (Medical Research Council Clinical Professor of Immunopharmacology and Honorary Consultant Physician within Medicine at The University of Southampton), Professor Lucy Chappell (Chief Scientific Adviser at Department for Health and Social Care), and Dr Thomas Waite (Interim Deputy Chief Medical Officer at Department for Health and Social Care)
Oral Evidence
20 October 2021
Work Committee on COP26 (Non-inquiry session)
Witnesses Alok Sharma, Peter Hill (Chief Executive Officer at COP26 Unit), Wasim Mir OBE (Chief Operating Officer at COP26 Unit), and Lee McDonough (Director General at Department for Business, Energy & Industrial Strategy)
Oral Evidence
20 October 2021
Work R&D Investment (Non-inquiry session)
Witnesses Sir John Kingman (Former Chair at UK Research and Innovation (UKRI)), Professor Dame Nancy Rothwell (President and Vice Chancellor at University of Manchester), Sir Paul Nurse, 2001 winner of the Nobel Prize in Physiology or Medicine, Professor Sir Peter Ratcliffe, 2019 winner of the Nobel Prize in Physiology or Medicine, Sir Adrian Smith (President at Royal Society), Sir Andrew Mackenzie (Chair at UK Research and Innovation (UKRI)), and Lord Browne of Madingley (Co-Chair at Medical Research Council)
Oral Evidence
23 September 2021
Inquiry The role of technology, research and innovation in the COVID-19 recovery
Witnesses Professor Richard Jones (Vice-President for Regional Innovation and Civic Engagement at University of Manchester), Professor Luke Gheorgiou (Deputy President and Deputy Vice-Chancellor at University of Manchester), Simon Cohen (CEO at Innovate Pharmaceuticals), Chris Oglesby (Exec Chair at Bruntwood SciTech, and CEO at Bruntwood), Richard Jeffery (National Director at GC Business), Dr Charles Knight (Associate Dean at University of Salford), Dr Marianne Sensier (Research Fellow at University of Manchester), and James Baker (CEO at Graphene@Manchester, University of Manchester)
Oral Evidence
21 July 2021
Inquiry The role of hydrogen in achieving Net Zero
Witnesses Guy Newey (Strategy and Performance Director at Energy Systems Catapult), Mark Neller (Director, Energy Business Leader UKIMEA at Arup), Kwasi Kwarteng (Secretary of State at Department for Business, Energy and Industrial Strategy), Professor Paul Monks (Chief Scientific Adviser at Department for Business, Energy and Industrial Strategy), and Sir Patrick Vallance, Government Chief Scientific Adviser
Oral Evidence
Total results 345 (page 4 of 18)